Category: Below Bottom Bollinger Band

Chart Scan – Dec 19, 2022

Chart Scan – Dec 19, 2022

ACB – Aurora Cannabis Inc.

ADEA – Adeia Inc.

ADPT – Adaptive Biotechnologies Corp.

AFRM – Affirm Holdings Inc.

AGRX – Agile Therapeutics Inc.

ARVL – Arrival Ltd.

ASTL – Algoma Steel Group Inc.

ATER – Aterian, Inc.

ATNF – 180 Life Sciences Corp.

BTBT – Bit Digital Inc.

CCCC – C4 Therapeutics Inc.

CELU – Celularity Inc.

CLOV – Clover Health Investments Corp.

COMM – CommScope, Inc.

CRBU – Caribou Biosciences Inc.

EDIT – Editas Medicine, Inc.

EVGO – EVgo Inc.

FIP – FTAI Infrastructure Inc.

FSTX – F-star Therapeutics, Inc.

GERN – Geron Corp.

GLDD – Great Lakes Dredge & Dock Corp.

GMBL – Esports Entertainment Group Inc.

GRPN – Groupon Inc.

HDSN – Hudson Technologies, Inc.

HOFV – Hall of Fame Resort & Entertainment Company

ICCM – Icecure Medical Ltd.

IMGN – ImmunoGen, Inc.

INO – Inovio Pharmaceuticals, Inc.

JAGX – Jaguar Health, Inc.

KZR – Kezar Life Sciences, Inc.

LAZR – Luminar Technologies, Inc.

LPRO – Open Lending Corp

LTRPA – Liberty TripAdvisor Holdings, Inc.

LWLG – Lightwave Logic, Inc.

LYLT – Loyalty Ventures Inc.

LYLTV – Loyalty Ventures Inc.

LZ – LegalZoom.com Inc.

MBIO – Mustang Bio, Inc.

MDXG – MiMedx Group, Inc.

ME – 23andMe Holding Co.

MRIN – Marin Software Inc.

MRSN – Mersana Therapeutics, Inc.

MVIS – Microvision, Inc.

MVST – Microvast Holdings, Inc.

NCMI – National CineMedia Inc.

NEPT – Neptune Technologies & BioResources Inc.

NKTX – Nkarta Inc.

NMRK – Newmark Group, Inc.

NNOX – Nano X Imaging Ltd.

OLPX – Olaplex Holdings Inc.

OPK – Opko Health Inc.

ORTX – Orchard Rx Ltd.

PAYO – Payoneer Global Inc.

PFSW – PFSweb, Inc.

PHUN – Phunware, Inc.

PLBY – PLBY Group, Inc.

PMVP – PMV Pharmaceuticals Inc.

PSNL – Personalis Inc.

QSI – HighCape Capital Acquisition Corp.

RAMMW – Aries I Acquisition Corp.

REAL – RealReal Inc.

RNW – ReNew Energy Global Plc

RXRX – Recursion Pharmaceuticals Inc.

SDC – SmileDirectClub Inc.

SEER – Seer Inc.

SELB – Selecta Biosciences, Inc.

SGMO – Sangamo Therapeutics, Inc.

SIEN – Sientra, Inc.

SKIN – The Beauty Health Company

SNDL – Sundial Growers Inc.

SOBR – Sobr Safe Inc.

SOND – Sonder Holdings Inc.

SPPI – Spectrum Pharmaceuticals, Inc.

SPRO – Spero Therapeutics, Inc.

SRNE – Sorrento Therapeutics, Inc.

SUNW – Sunworks, Inc.

TSHA – Taysha Gene Therapies Inc.

VBIV – VBI Vaccines Inc.

VLDR – Velodyne Lidar, Inc.

VXRT – Vaxart, Inc.

WETG – WeTrade Group

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 16, 2022

Chart Scan – Dec 16, 2022

ACHL – Achilles Therapeutics Plc

ADMP – Adamis Pharmaceuticals Corp.

AGFY – Agrify Corp.

AKLI – Akili, Inc.

AKTS – Akoustis Technologies, Inc.

APPH – AppHarvest, Inc.

ARBK – Argo Blockchain Plc

ARKO – ARKO Corp.

ATNX – Athenex, Inc.

BNGO – Bionano Genomics, Inc.

CAN – Canaan Inc

CETX – Cemtrex Inc.

CIFR – Cipher Mining Inc.

CLLS – Cellectis SA

EDBL – Edible Garden AG Inc.

ERIC – Ericsson Telephone Co.

EYPT – EyePoint Pharmaceuticals, Inc.

GREE – Greenidge Generation Holdings, Inc.

HUT – Hut 8 Mining Corp.

IHRT – iHeartMedia Inc.

IPHA – Innate Pharma

LAB – Standard BioTools Inc.

LAUR – Laureate Education, Inc.

MARA – Marathon Digital Holdings Inc

MARK – Remark Holdings, Inc.

MGTA – Magenta Therapeutics, Inc.

MNTS – Momentus Inc.

MOR – MorphoSys AG

MREO – Mereo BioPharma Group Plc

OBSV – ObsEva SA

OMER – Omeros Corp.

ORGN – Origin Materials Inc.

PEAR – Pear Therapeutics Inc.

QRTEA – Qurate Retail, Inc.

RTL – The Necessity Retail REIT, Inc.

SFIX – Stitch Fix, Inc.

SINT – SiNtx Technologies, Inc.

SLGC – SomaLogic, Inc.

SNCE – Science 37 Holdings, Inc.

SNPX – Synaptogenix Inc.

SURF – Surface Oncology, Inc

SWVL – Swvl Holdings Corp

TMC – TMC the Metals Company Inc.

TRUE – TrueCar Inc.

TSLL – Direxion Daily TSLA Bull 1.5X Shares

VERU – Veru Inc.

WISH – ContextLogic Inc.

RBOT – Vicarious Surgical Inc.

RITM – Rithm Capital Corp.

RWT – Redwood Trust, Inc.

SPIR – Spire Global, Inc.

VLRS – Controladora Vuela Compania de Aviacion

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 15, 2022

Chart Scan – Dec 15, 2022

AKU – Akumin Inc.

ALLO – Allogene Therapeutics, Inc.

ALLT – Allot Ltd.

ALTO – Alto Ingredients Inc

ATRA – Atara Biotherapeutics, Inc.

AVPT – AvePoint Inc.

AXLA – Axcella Health Inc.

CENX – Century Aluminum Co.

CFFN – Capitol Federal Financial

CGEN – Compugen Ltd.

CLOV – Clover Health Investments Corp.

CLSK – CleanSpark, Inc.

CRBU – Caribou Biosciences Inc.

DSEY – Diversey Holdings Ltd.

GPRO – GoPro, Inc.

HEXO – Hexo Corp.

HOOD – Robinhood Markets Inc.

IMPP – Imperial Petroleum Inc.

INVZ – Innoviz Technologies Ltd.

KOPN – Kopin Corp.

KZR – Kezar Life Sciences, Inc.

LASR – Nlight, Inc.

LAZR – Luminar Technologies, Inc.

LHDX – Lucira Health Inc.

LYEL – Lyell Immunopharma Inc.

MCRB – Seres Therapeutics, Inc.

NVTS – Navitas Semiconductor Corporation

PAYO – Payoneer Global Inc.

PSTV – Plus Therapeutics Inc.

REE – REE Automotive Ltd

RELY – Remitly Global Inc.

RMNI – Rimini Street, Inc.

SANA – Sana Biotechnology Inc.

SESN – Sesen Bio, Inc.

SGMO – Sangamo Therapeutics, Inc.

SIRI – Sirius XM Holdings Inc.

SPWH – Sportsman’s Warehouse Holdings, Inc.

STRC – Sarcos Technology and Robotics Corporation

THRD – Third Harmonic Bio Inc.

TNXP – Tonix Pharmaceuticals Holding Corp.

VERB – Verb Technology Co., Inc.

USA – Liberty All Star Eqty Fund

USER – UserTesting Inc.

VIV – Telefonica Brasil SA

WIT – Wipro Ltd.

WOW – Wideopenwest, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 14, 2022

Chart Scan – Dec 14, 2022

ALZN – Alzamend Neuro Inc.

APVO – Aptevo Therapeutics Inc.

ASPU – Aspen Group, Inc.

BGXX – Bright Green Corp.

BXRX – Baudax Bio Inc.

EVLV – Evolv Technologies Holdings, Inc.

FULC – Fulcrum Therapeutics Inc.

HUMA – Humacyte, Inc.

JZXN – Jiuzi Holdings Inc.

MAPS – WM Technology, Inc.

MVIS – Microvision, Inc.

ONDS – Ondas Holdings Inc.

OP – OceanPal Inc.

OTLK – Outlook Therapeutics, Inc.

SKYX – SQL Technologies Corp.

SPRC – SciSparc Ltd.

STKL – SunOpta Inc.

TIL – Instil Bio Inc.

VRAX – Virax Biolabs Group Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 13, 2022

Chart Scan – Dec 13, 2022

ADMP – Adamis Pharmaceuticals Corp.

ARBK – Argo Blockchain Plc

ASTL – Algoma Steel Group Inc.

CFRX – ContraFect Corp.

CLVS – Clovis Oncology, Inc.

CONN – Conn’s, Inc.

CRVS – Corvus Pharmaceuticals, Inc.

GNUS – Genius Brands International, Inc.

HYFM – Hydrofarm Holdings Group Inc.

JBLU – JetBlue Airways Corp.

JOAN – JOANN Inc.

MLGO – MicroAlgo, Inc.

MMAT – Meta Materials Inc.

SEV – Sono Group N.V.

SOLO – Electrameccanica Vehicles Corp.

TCDA – Tricida, Inc.

TMC – TMC the Metals Company Inc.

TSLL – Direxion Daily TSLA Bull 1.5X Shares

VNDA – Vanda Pharmaceuticals Inc.

VVPR – VivoPower International PLC

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 12, 2022

Chart Scan – Dec 12, 2022

AFMD – Affimed Therapeutics BV

ALLO – Allogene Therapeutics, Inc.

AREB – American Rebel Holdings Inc.

CRIS – Curis, Inc.

DUO – Fangdd Network Group Ltd

INSG – Inseego Corp.

JNCE – Jounce Therapeutics, Inc.

KPTI – Karyopharm Therapeutics Inc.

NMRK – Newmark Group, Inc.

PSTV – Plus Therapeutics Inc.

VKTX – Viking Therapeutics, Inc.

VYNE – VYNE Therapeutics, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 09, 2022

Chart Scan – Dec 09, 2022

ALTO – Alto Ingredients Inc

ASTL – Algoma Steel Group Inc.

BIOR – Biora Therapeutics, Inc.

CMRX – Chimerix, Inc.

COMM – CommScope, Inc.

EQRX – EQRx Inc.

ERAS – Erasca Inc.

ESPR – Esperion Therapeutics, Inc.

FLGC – Flora Growth Corp.

FULC – Fulcrum Therapeutics Inc.

HOOK – HOOKIPA Pharma Inc.

KWE – KWESST Micro Systems Inc.

LYEL – Lyell Immunopharma Inc.

MMAT – Meta Materials Inc.

NNDM – Nano Dimension Ltd.

SEV – Sono Group N.V.

SOND – Sonder Holdings Inc.

SPRO – Spero Therapeutics, Inc.

STRC – Sarcos Technology and Robotics Corporation

TGTX – TG Therapeutics, Inc.

TTI – TETRA Technologies

USA – Liberty All Star Eqty Fund

WIT – Wipro Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 08, 2022

Chart Scan – Dec 08, 2022

ADV – Advantage Solutions Inc.

CDTX – Cidara Therapeutics, Inc.

CNTX – Context Therapeutics Inc.

EIGR – Eiger BioPharmaceuticals, Inc.

INVZ – Innoviz Technologies Ltd.

JBLU – JetBlue Airways Corp.

LITM – Snow Lake Resources Ltd.

METC – Ramaco Resources, Inc.

OPGN – OpGen, Inc.

REED – Reeds, Inc.

RLMD – Relmada Therapeutics, Inc.

RMNI – Rimini Street, Inc.

RXT – Rackspace Technology Inc.

STGW – Stagwell Inc.

SXTC – China SXT Pharmaceuticals, Inc.

TCRR – TCR2 Therapeutics Inc.

XXII – 22nd Century Group, Inc.

SWN – Southwestern Energy Co.

TCN – Tricon Residential Inc.

TEF – Telefonica SA

ZYME – Zymeworks Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 07, 2022

Chart Scan – Dec 07, 2022

AMTX – Aemetis, Inc.

ANGI – Angie’s List Inc.

APLD – Applied Blockchain, Inc.

BIOR – Biora Therapeutics, Inc.

BRSH – Bruush Oral Care Inc.

CGNT – Cognyte Software Ltd.

CLVS – Clovis Oncology, Inc.

DAKT – Daktronics, Inc.

ENSC – Ensysce Biosciences Inc.

EZPW – EZCORP, Inc.

GROM – Grom Social Enterprises Inc.

LILAK – Liberty LiLAC Group, Inc.

LTCH – TS Innovation Acquisitions Corp.

LTRPA – Liberty TripAdvisor Holdings, Inc.

MCRB – Seres Therapeutics, Inc.

PBTS – Powerbridge Technologies Co., Ltd.

PRLD – Prelude Therapeutics Inc.

RBBN – Ribbon Communications Inc.

SPRO – Spero Therapeutics, Inc.

SWBI – Smith & Wesson Brands, Inc.

UNIT – Uniti Group Inc.

VFF – Village Farms International, Inc.

VS – Versus Systems Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 06, 2022

Chart Scan – Dec 06, 2022

ALTO – Alto Ingredients Inc

ASTS – AST SpaceMobile, Inc.

ATOS – Atossa Genetics, Inc.

BBIG – Vinco Ventures, Inc.

BOXL – Boxlight Corporation

CRKN – Crown ElectroKinetics Corp.

GOSS – Gossamer Bio, Inc.

IMUX – Vital Therapies, Inc.

MBIO – Mustang Bio, Inc.

MEIP – MEI Pharma, Inc.

MVST – Microvast Holdings, Inc.

NNDM – Nano Dimension Ltd.

OPEN – Opendoor Technologies Inc.

PBLA – Panbela Therapeutics, Inc.

SDIG – Stronghold Digital Mining Inc.

TSP – TuSimple Holdings Inc.

UROY – Uranium Royalty Corp.

VKTX – Viking Therapeutics, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.